Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 121,832 | 238,616 | 105,202 | -43,032 | -157,833 |
| Depreciation Amortization | 72,971 | 278,253 | 206,581 | 135,087 | 79,374 |
| Income taxes - deferred | -19,110 | -136,937 | -120,909 | -82,768 | -63,976 |
| Accounts receivable | -18,245 | -38,647 | -5,004 | 3,640 | 37,861 |
| Accounts payable and accrued liabilities | 51,292 | -18,935 | 20,645 | 5,264 | 19,604 |
| Other Working Capital | 50,282 | -85,437 | 13,978 | 8,712 | 43,948 |
| Other Operating Activity | 25,975 | 662,735 | 492,884 | 428,585 | 313,991 |
| Operating Cash Flow | $284,997 | $899,648 | $713,377 | $455,488 | $272,969 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 739,300 | -642,675 | -741,750 | -1,040,475 | -185,000 |
| PPE Investments | -2,168 | -15,004 | -10,889 | -7,520 | -4,830 |
| Net Acquisitions | N/A | 14,259 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | 565,000 | 345,000 |
| Purchase Sale Intangibles | 0 | -364,250 | -328,250 | -318,250 | -215,250 |
| Other Investing Activity | 0 | -364,250 | -328,250 | -318,250 | -215,250 |
| Investing Cash Flow | $737,132 | $-1,007,670 | $-1,080,889 | $-801,245 | $-60,080 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,481,381 | 1,481,381 | 1,481,381 | N/A |
| Debt Repayment | -8,347 | -889,575 | -881,228 | -849,581 | -8,347 |
| Common Stock Issued | 50,407 | 99,681 | 34,339 | 24,251 | 13,264 |
| Common Stock Repurchased | N/A | -146,537 | -146,537 | -146,537 | -139,053 |
| Other Financing Activity | -23,784 | -16,877 | -15,760 | -14,663 | -13,547 |
| Financing Cash Flow | $18,276 | $528,073 | $472,195 | $494,851 | $-147,683 |
| Exchange Rate Effect | -641 | 374 | -85 | -356 | -948 |
| Beginning Cash Position | 1,057,769 | 637,344 | 637,344 | 637,344 | 637,344 |
| End Cash Position | 2,097,533 | 1,057,769 | 741,942 | 786,082 | 701,602 |
| Net Cash Flow | $1,039,764 | $420,425 | $104,598 | $148,738 | $64,258 |
| Free Cash Flow | |||||
| Operating Cash Flow | 284,997 | 899,648 | 713,377 | 455,488 | 272,969 |
| Capital Expenditure | -2,168 | -15,004 | -10,889 | -7,520 | -4,830 |
| Free Cash Flow | 282,829 | 884,644 | 702,488 | 447,968 | 268,139 |